Your browser doesn't support javascript.
Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
Fonager, Jannik; Bennedbæk, Marc; Bager, Peter; Wohlfahrt, Jan; Ellegaard, Kirsten Maren; Ingham, Anna Cäcilia; Edslev, Sofie Marie; Stegger, Marc; Sieber, Raphael Niklaus; Lassauniere, Ria; Fomsgaard, Anders; Lillebaek, Troels; Svarrer, Christina Wiid; Møller, Frederik Trier; Møller, Camilla Holten; Legarth, Rebecca; Sydenham, Thomas Vognbjerg; Steinke, Kat; Paulsen, Sarah Juel; Castruita, José Alfredo Samaniego; Schneider, Uffe Vest; Schouw, Christian Højte; Nielsen, Xiaohui Chen; Overvad, Maria; Nielsen, Rikke Thoft; Marvig, Rasmus L; Pedersen, Martin Schou; Nielsen, Lene; Nilsson, Line Lynge; Bybjerg-Grauholm, Jonas; Tarpgaard, Irene Harder; Ebsen, Tine Snejbjerg; Lam, Janni Uyen Hoa; Gunalan, Vithiagaran; Rasmussen, Morten.
  • Fonager J; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Bennedbæk M; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Bager P; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Wohlfahrt J; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Ellegaard KM; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Ingham AC; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Edslev SM; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Stegger M; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Sieber RN; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Lassauniere R; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Fomsgaard A; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Lillebaek T; International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
  • Svarrer CW; Global Health Section, University of Copenhagen, Copenhagen, Denmark.
  • Møller FT; Department of Bacteria, Parasites, and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Møller CH; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Legarth R; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Sydenham TV; Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.
  • Steinke K; Department of Clinical Microbiology, Odense University Hospital, Denmark.
  • Paulsen SJ; Department of Clinical Microbiology, Odense University Hospital, Denmark.
  • Castruita JAS; Department of Clinical Microbiology, Copenhagen University Hospital Amager-Hvidovre, Hvidovre, Denmark.
  • Schneider UV; Department of Clinical Microbiology, Copenhagen University Hospital Amager-Hvidovre, Hvidovre, Denmark.
  • Schouw CH; Department of Clinical Microbiology, Copenhagen University Hospital Amager-Hvidovre, Hvidovre, Denmark.
  • Nielsen XC; Department of Clinical Microbiology, Zealand University Hospital, Køge, Denmark.
  • Overvad M; Department of Clinical Microbiology, Zealand University Hospital, Køge, Denmark.
  • Nielsen RT; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Marvig RL; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Pedersen MS; Center for Genomic Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Nielsen L; Department of Clinical Microbiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Nilsson LL; Department of Clinical Microbiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Bybjerg-Grauholm J; Department of Clinical Microbiology, Copenhagen University Hospital-Herlev and Gentofte, Herlev, Denmark.
  • Tarpgaard IH; Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
  • Ebsen TS; Clinical Microbiology Department, Aarhus University Hospital, Aarhus, Denmark.
  • Lam JUH; Clinical Microbiology Department, Aarhus University Hospital, Aarhus, Denmark.
  • Gunalan V; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Rasmussen M; Virus Research and Development Laboratory, Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill ; 27(10)2022 03.
Article in English | MEDLINE | ID: covidwho-1742167
ABSTRACT
Following emergence of the SARS-CoV-2 variant Omicron in November 2021, the dominant BA.1 sub-lineage was replaced by the BA.2 sub-lineage in Denmark. We analysed the first 2,623 BA.2 cases from 29 November 2021 to 2 January 2022. No epidemiological or clinical differences were found between individuals infected with BA.1 versus BA.2. Phylogenetic analyses showed a geographic east-to-west transmission of BA.2 from the Capital Region with clusters expanding after the Christmas holidays. Mutational analysis shows distinct differences between BA.1 and BA.2.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.10.2200181

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.10.2200181